Recurrent pregnancy loss and its relation to FV Leiden, FII G20210A and polymorphisms of plasminogen activator and plasminogen activator inhibitor

Pathophysiology of Haemostasis and Thrombosis

Volumn 33, Issue 3, 2003, Pages 134-137

  Wolf, Cornelia E ^a   Haubelt, Hannelore ^b   Pauer, Hans Ulrich ^a   Hinney, Bernd ^a   Krome Cesar, Claudette ^a   Legler, Tobias J ^a   Hellsterne, Peter ^b   Emons, Günter ^a   Zoll, Barbara ^a   Köhler, Michael ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b KLINIKUM LUDWIGSHAFEN   (Germany)

Author keywords

Abortion; Factor V Leiden mutation; PAI 1 gene polymorphism; t PA Alu I gene polymorphism

Indexed keywords

BLOOD CLOTTING FACTOR 12; BLOOD CLOTTING FACTOR 5 LEIDEN; PLASMINOGEN ACTIVATOR; PLASMINOGEN ACTIVATOR INHIBITOR; PROTEIN C; PROTEIN S;

ADULT; ARTICLE; BLOOD CLOTTING DISORDER; BLOOD CLOTTING FACTOR 12 DEFICIENCY; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; FEMALE INFERTILITY; GENE MUTATION; HETEROZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN C DEFICIENCY; PROTEIN S DEFICIENCY; RECURRENT ABORTION;

ABORTION, HABITUAL; ADULT; BLOOD COAGULATION FACTORS; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; FACTOR V; FEMALE; GENE FREQUENCY; HUMANS; INFERTILITY, FEMALE; PLASMINOGEN ACTIVATOR INHIBITOR 1; PLASMINOGEN ACTIVATORS; POLYMORPHISM, GENETIC; PREGNANCY; PREGNANCY COMPLICATIONS, HEMATOLOGIC; PROSPECTIVE STUDIES; PROTHROMBIN; THROMBOPHILIA;

EID: 2542600798     PISSN: 14248832     EISSN: None     Source Type: Journal    
DOI: 10.1159/000077821     Document Type: Article

References (24)

1. Stirrat GM: Recurrent miscarriage. I. Definition and epidemiology (review). Lancet 1990;336:673-675.
2. Karrison TG, Ober C: Recurrent miscarriage (REMIS) study: How should data from women who do not become pregnant be handled? Control Clin Trials 1998;19:430-439.
3. Chandra A, Stephen EH: Impaired fecundity in the United States: 1982-1995. Fam Plan Perspect 1998;30:34-42.
4. Stephen EH: Projections of impaired fecundity among women in the United States: 1995 to 2020. Feril Steril 1996;66:202-204.
5. Stirrat GM: Recurrent miscarriage. II. Clinical associations, causes, and management (review). Lancet 1990;336:728-733.
6. Brenner B: Inherited thrombophilia and pregnancy loss (review). Thromb Haemost 1999;82:634-640.
7. Gris JC, Ripart-Neveu S, Maugard C, Tailland ML, Brun S, Courtieu C, Biron C, Hoffet M, Hédon B, Màres P: Prospective evaluation of the prevalence of haemostasis abnormalities in primary early recurrent miscarriages. Thromb Haemost 1997;77:1096-1103.
8. Lane DA, Grant PJ: Role of hemostatic gene polymorphisms in venous and arterial thrombotic disease (review article). Blood 2000;95:1517-1532.
9. Miller SA, Dykes DD, Polesky HF: A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988;16:1215.
10. Falk G, Svensson H, Almqvist A, Wiman B: Allele specific PCR for detection of a sequence polymorphism in the promotor region of the plasminogen activator inhibitor-1 (PAI-1) gene. Fibrinolysis 1995;9:170-174.
11. van der Bom JG, de Knijff P, Haverkate F, Bots ML, Meijer P, de Jong PT, Hofman A, Kluft C, Grobbee DE: Tissue plasminogen activator and risk of myocardial infarction. Circulation 1997;95:2623-2627.
12. Ridker PM, Hennekens CH, Lindpaintner K, Stampfer MJ, Eisenberg PR, Miletich JP: Mutation in the gene coding for coagulation factor V and the risk of myocardial infarction, stroke, and venous thrombosis in apparently healthy men. N Engl J M 1995;332:912-917.
13. Poort SR, Rosendaal FR, Reitsma PH, Bertina RM: A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 1996;88:3698-3703.
14. Haubelt H, Blome M, Kiessling AH, Isgro F, Bach J, Saggau W, Hellstern P: Effects of solvent/detergent-treated plasma and fresh-frozen plasma on haemostasis and fibrinolysis in complex coagulopathy following open-heart surgery. Vox Sang 2002;82:9-14.
15. Pickering W, Holmes Z, Regan L: Normal prevalence of the G20210A prothrombin gene mutation in women with recurrent miscarriage (abstract). Br J Haematol 1998;102:250.
16. Yamada H, Kato EH, Kobashi G, Ebina Y, Shimada S, Morikawa M, Yamada T, Sakuragi N, Fujimoto S: Recurrent pregnancy loss: etiology of thrombophilia. Semin Thromb Hemost 2001;27:121-129.
17. Rai R, Shlebak A, Cohen H, Backos M, Holmes Z, Marriott K, Regan L: Factor V Leiden and acquired activated protein C resistance among 1,000 women with recurrent miscarriage. Hum Reprod 2001;16:961-965.
18. Braulke I, Hinney B, Pruggmyer M, Köstering H, Melloh P, Günther E: Factor (Hagemann) XII deficiency in women with habitual abortion: New subpopulation of recurrent aborters? Fertil Steril 1993;59:98-101.
19. Schloesser M, Zeerleder S, Lutze G, Halbmayer WM, Hofferbert S, Hinney B, Koestering H, Lämmle B, Pindur G, Thies K, Köhler M, Engel W: Mutations in the human factor XII gene. Blood 1997;90:3967-3977.
20. Martinelli I, Taioli E, Cetin I, Marinoni A, Gerosa S, Villa MV, Bozzo M, Mannucci PM: Mutations in coagulation factors in women with unexplained late fetal loss. N Engl J Med 2000;343:1015-1018.
21. Bauer KA: Conventional fibrinolytic assays for the evaluation of patients with venous thrombosis: Don't bother. Thromb Haemost 2001;85:377-378.
22. Franco RF, Reitsma PH: Gene polymorphisms of the haemostatic system and the risk of arterial thrombotic disease. Br J Haematol 2001;115:491-500.
23. Ladenvall P, Wall U, Jern S, Jern C: Identification of eight novel single-nucleotide polymorphisms at human tissue-type plasminogen activator (t-PA) locus: Association with vascular t-PA release in vivo. Thromb Haemost 2000;84:150-155.
24. Glueck CJ, Kupferminc MJ, Fontaine RN, Wang P, Weksler BB, Eldor A: Genetic hypofibrinolysis in complicated pregnancies. Obstet Gynecol 2001;97:44-48.